In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify marijuana as being a Routine III drug. This rescheduling will acknowledge that cannabis has legitimate medical functions and will help open the doorway to investigation on other opportunity cure works by